Petra Muus
Altera (United States)(US)Leeds Teaching Hospitals NHS Trust(GB)St James's University Hospital(GB)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Complement system in diseases, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Blood groups and transfusion
Most-Cited Works
- → Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome(2013)1,539 cited
- → The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria(2006)1,254 cited
- → Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria(2007)576 cited
- → Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group(2011)547 cited
- → A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q(2011)476 cited
- → Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.